Scott L. Dax

Identification and Biological Evaluation of 4-(3-Trifluoromethylpyridin-2-yl)piperazine-1-carboxylic Acid (5-Trifluoromethylpyridin-2-yl)amide, a High Affinity TRPV1 (VR1) Vanilloid Receptor Antagonist

Devin M. Swanson, Adrienne E. Dubin, Chandra Shah et al. · Journal of Medicinal Chemistry · 2004 · 183 citations · Full text

Drug Target, High Throughput, High Affinity Trpv1 +17

Multi-Component Methodologies in Solid-Phase Organic Synthesis

Scott L. Dax, James J. McNally, Mark A. Youngman · Current Medicinal Chemistry · 1999 · 106 citations

Combinatorial Chemistry, Chemical Engineering, Diversity Oriented Synthesis +13

Mannich reactions of resin-bound substrates: 2. A versatile three-component solid-phase organic synthesis methodology

James J. McNally, Mark A. Youngman, Scott L. Dax · Tetrahedron Letters · 1998 · 85 citations

Materials Science, Engineering, Sustainable Synthesis +8

An efficient desilylation method for the generation of o-quinone methides: application to the synthesis of (+)- and (-)-hexahydrocannabinol

Joseph P. Marino, Scott L. Dax · The Journal of Organic Chemistry · 1984 · 78 citations

Cannabis Use, Engineering, Biochemistry +14

JNJ-20788560 [9-(8-Azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic Acid Diethylamide], a Selective Delta Opioid Receptor Agonist, Is a Potent and Efficacious Antihyperalgesic Agent That Does Not Produce Respiratory Depression, Pharmacologic Tolerance, or Physical Dependence

Ellen E. Codd, John R. Carson, Raymond W. Colburn et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 67 citations